To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Platelet-Rich Plasma vs. Autologous Blood Injection for Plantar Fasciitis

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
November 2022

Platelet-Rich Plasma vs. Autologous Blood Injection for Plantar Fasciitis

Vol: 302| Issue: 1| Number:6| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Platelet-Rich Plasma vs Autologous Blood Injection to Treat Plantar Fasciitis: A Prospective Randomized, Double-Blinded, Controlled Trial

Foot Ankle Int . 2022 Sep;43(9):1211-1218.

Contributing Authors:
C Bildik O Kaya

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty patients with plantar fasciitis were randomized to receive an ultrasound-guided injection of platelet-rich plasma (n=30) or autologous blood product. The outcomes of interest included pain on a Visual Analog Scale (VAS) and the Foot and Ankle Disability Index (FADI), measured at 1, 3 and 6 months. Results revealed no significant differences between the two groups in all outcomes, at all time...

Join the Conversation

Please Login or Join to leave comments.